Sign In / Register          (0)
logo
Phage Assisted Continuous Evolution (PACE)

Phage Assisted Continuous Evolution (PACE)

Phage-Assisted Continuous Evolution (PACE) is a revolutionary technology for accelerating the evolution of gene-encoded molecules. By linking the desired molecular activity to phage propagation in Escherichia coli, PACE enables continuous, high-throughput directed evolution over multiple generations without manual intervention. This approach has transformed the landscape of protein engineering, allowing researchers to generate enzymes, binding proteins, and other biomolecules with enhanced stability, specificity, or catalytic efficiency.

At Profacgen, we provide a comprehensive PACE platform tailored to diverse client needs, from academic research to industrial biotechnology. Our platform integrates advanced phage engineering, customizable selection strategies, and rigorous analytical pipelines, enabling rapid evolution of target proteins under precisely controlled conditions.

Background

Directed Evolution and Its Importance

Directed evolution is a cornerstone of modern protein engineering. By mimicking natural selection in the laboratory, researchers can iteratively optimize biomolecules for improved properties such as:

Traditional directed evolution requires iterative rounds of mutation, selection, and amplification, which can be labor-intensive and time-consuming.

PACE: Continuous Evolution at the Speed of Life

Phage-Assisted Continuous Evolution addresses these challenges by coupling the desired activity of a target gene to the life cycle of a bacteriophage. Key features include:

The system was pioneered by David Liu and colleagues, who demonstrated its ability to evolve polymerases, proteases, and other enzymes in a continuous, automated manner.

Overview of the phage-assisted continuous evolution systemFigure 1. Overview of the PACE system. (Esvelt et al., 2011)

Advantages of PACE Over Traditional Methods

Compared to classical in vitro evolution or iterative mutagenesis, PACE offers several distinct advantages:

Our Service Offerings

Profacgen provides advanced, personalized PACE services for research institutions and biotechnology companies. Our offerings encompass the full spectrum of directed evolution, from experimental design to final validation.

PACE System Customization

  • Tailored selection strategies based on target molecule properties
  • Optimization of phage and host strain configurations
  • Design of multiple helper plasmids to support phage propagation
  • Engineering of mutation-inducing plasmids for controlled variability

Library Preparation and Screening

  • Generation of diverse protein libraries for continuous evolution
  • Screening in whole cells or cell lysates
  • Activity-dependent selection to enrich desired variants
  • High-throughput monitoring of phage replication and target function

Protein Variant Optimization

  • Directed evolution for thermal, chemical, or proteolytic stability
  • Selection for improved catalytic efficiency or substrate specificity
  • Enhanced expression and solubility of recombinant proteins

Phage and Host Engineering

  • Construction of modified bacteriophages carrying target genes
  • Strategic placement of helper plasmids in host bacteria to optimize phage proliferation
  • Minimization of interference between genetic elements for robust evolution

Analytical Validation

  • Sequencing of evolved variants to confirm desired mutations
  • Functional assays to quantify activity, stability, and specificity
  • Comparative analysis with starting libraries to assess evolutionary progress

Data Integration and Reporting

  • Comprehensive documentation of experimental parameters, selection pressures, and outcomes
  • Detailed reports of variant sequences, phenotypes, and functional metrics
  • Consultation for downstream applications or commercialization

Inquiry

Service Workflow

Workflow for phage-assisted continuous evolution services

Our Service Advantages

Representative Case Studies

Case 1: Thermostable Enzyme Evolution

Challenge:

A client required a polymerase capable of functioning at high temperatures for industrial applications. Existing variants exhibited insufficient thermal stability, limiting performance in demanding reaction conditions.

Approach:

Profacgen created a diversified polymerase library through targeted mutagenesis and recombination. Phage-Assisted Continuous Evolution (PACE) was applied with a temperature-dependent selection pressure that progressively increased over successive generations. The continuous evolution platform enabled iterative rounds of mutation, selection, and replication without manual intervention.

Outcome:

Identified polymerase variants with significantly enhanced thermal stability compared to the parental enzyme. Evolved candidates demonstrated improved activity at elevated temperatures while maintaining high fidelity, enabling robust performance under industrial processing conditions and providing a commercially viable enzyme for the client's application.

Case 2: Protease-Resistant Protein Development

Challenge:

A research group sought to evolve a therapeutic protein resistant to proteolytic degradation, which was compromising in vivo stability and limiting efficacy. Conventional rational design approaches had failed to identify stabilizing mutations.

Approach:

Profacgen introduced the target gene into phage vectors with controlled mutation rates to generate diverse variant libraries. During continuous evolution, a protease selection pressure was applied, allowing only variants with enhanced resistance to propagate. The PACE platform automatically enriched for sequences conferring improved proteolytic stability over multiple generations.

Outcome:

Evolved protein variants exhibited robust resistance to proteases and denaturants while preserving functional activity. Selected candidates also demonstrated improved expression yields. The evolved therapeutic protein offered enhanced stability for downstream formulation and in vivo applications, advancing the client's development program.

Case 3: Library Screening for Enhanced Catalytic Activity

Challenge:

An enzyme engineering company needed to rapidly identify highly active variants from a large combinatorial library. Traditional screening methods were time-consuming and limited in throughput, delaying the identification of optimal candidates.

Approach:

Profacgen utilized PACE to directly link enzyme activity to phage propagation efficiency. The continuous evolution system was configured such that only variants with enhanced catalytic activity supported robust phage replication. Activity-dependent enrichment was monitored in real time throughout the evolution campaign, enabling dynamic assessment of library performance.

Outcome:

Achieved rapid identification of high-activity variants from a complex combinatorial library, dramatically accelerating the discovery timeline. Top candidates were sequenced to map beneficial mutations, revealing key residues responsible for improved catalysis. The streamlined platform delivered validated enzyme variants with superior activity, enabling the client to advance lead candidates efficiently.

Consult Our Experts on Your Project

Frequently Asked Questions (FAQs)

Q: What types of proteins can be evolved using PACE?
A: PACE is applicable to polymerases, proteases, binding proteins, enzymes, transcription factors, and other gene-encoded molecules where activity can be linked to phage propagation.
A: PACE is continuous and automated, directly linking molecular activity to phage replication. It enables multiple evolutionary cycles per day without manual intervention, dramatically accelerating timelines.
A: PACE can accommodate libraries ranging from 105 to 109 variants, depending on the selection design, host system, and specific functional requirements of the target.
A: Yes, selection pressures can be carefully designed to target multiple functional attributes concurrently, enabling directed evolution toward complex, multi-parameter optimization goals.
A: Evolved variants are sequenced to identify beneficial mutations and subsequently subjected to functional, stability, and expression assays to confirm desired improvements.
A: Absolutely. We implement strict confidentiality protocols, including secure data handling and IP protection measures, to safeguard client proprietary information and commercial interests.
A: Timelines vary with target complexity and library size, but initial evolution cycles and variant identification can often be completed within a few weeks.

References:

  1. Esvelt KM, Carlson JC, Liu DR. A system for the continuous directed evolution of biomolecules. Nature. 2011;472(7344):499-503. doi:10.1038/nature09929
Online Inquiry

Fill out this form and one of our experts will respond to you within one business day.